GO:0032585 multivesicular body membrane: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032585 (multivesicular body membrane) is the lipid bilayer that surrounds a multivesicular body (MVB), the endosomal compartment containing intraluminal vesicles.
• The MVB membrane is the site where ESCRT complexes and associated proteins sort cargo and drive inward budding of intraluminal vesicles.
• MVB membrane dynamics are central to exosome biogenesis, because intraluminal vesicles can be released as exosomes upon MVB fusion with the plasma membrane.
• Key molecular players at the MVB membrane include ESCRT-0, -I, -II, -III, VPS4, ALIX, syntenin, and the ceramide-producing enzyme nSMase2.
• Dysregulation of MVB membrane function is linked to cancer progression, metastasis, and neurodegenerative disease through altered exosome cargo and secretion.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of MVB membrane genes in exosome biology and disease.
Description
The multivesicular body membrane (GO:0032585) is defined as the lipid bilayer surrounding a multivesicular body, an endosomal organelle that contains numerous intraluminal vesicles formed by inward budding of the limiting membrane. This membrane is not a passive barrier; it is a dynamic platform where cargo sorting, membrane deformation, and vesicle scission occur. Because intraluminal vesicles can be secreted as exosomes, the MVB membrane sits at the crossroads of endosomal trafficking and intercellular communication. Researchers study GO:0032585 to understand how cells package proteins, lipids, and RNAs into vesicles, and how these processes are hijacked in cancer and other diseases. The MVB membrane also participates in specialized trafficking pathways, such as stimulus-regulated transport in olfactory cilia. Consequently, the term is a focal point for cell biology, cancer research, and therapeutic development.
multivesicular body membrane At A Glance
| GO ID | GO:0032585 |
|---|---|
| GO term | multivesicular body membrane |
| Ontology | cellular_component |
| Synonym | multivesicular endosome membrane; MVB membrane; MVE membrane |
| Major function | Lipid bilayer surrounding the multivesicular body; platform for cargo sorting and intraluminal vesicle formation |
| Related process | Exosome biogenesis and secretion |
| Key machinery | ESCRT-0, -I, -II, -III, VPS4, ALIX, syntenin |
| Disease relevance | Cancer metastasis, neurodegeneration, and other exosome-linked pathologies |
What Is GO:0032585?
In the Gene Ontology, GO:0032585 (multivesicular body membrane) refers to the lipid bilayer that surrounds a multivesicular body. A multivesicular body is an endosomal structure whose limiting membrane invaginates to form intraluminal vesicles, creating a compartment that is topologically distinct from the cytosol. The term is a cellular component and is synonymous with multivesicular endosome membrane, MVB membrane, and MVE membrane. It encompasses the protein and lipid environment of the MVB limiting membrane, including ESCRT machinery and associated factors that mediate sorting and vesicle formation.
Why Is multivesicular body membrane Important in Cell Biology?
The multivesicular body membrane is important because it defines the boundary and functional surface of the MVB, the organelle responsible for sorting cargo into intraluminal vesicles that can be degraded or secreted as exosomes. This membrane is where ESCRT complexes assemble and where membrane bending and scission occur, making it a central node in endosomal trafficking. Because exosomes influence intercellular communication in cancer, immunity, and regeneration, understanding the MVB membrane has direct implications for disease mechanisms and therapeutic strategies.
• Controls exosome biogenesis by hosting the inward budding machinery that generates intraluminal vesicles.
• Serves as the assembly platform for ESCRT-0, -I, -II, and -III complexes that sort ubiquitinated cargo.
• Regulates the release of exosomes that mediate intercellular communication in cancer and regenerative medicine.
• Is implicated in cancer metastasis through proteins such as GPR143 that control ESCRT-dependent exosome biogenesis.
• Participates in specialized trafficking pathways, including stimulus-regulated transport in olfactory cilia.
• Provides a target for therapeutic modulation of exosome secretion in disease.
• Is essential for membrane remodeling events that require precise lipid and protein composition.
• Links endosomal sorting to neurodegenerative disease through altered exosome cargo.
What Happens During multivesicular body membrane?
Cargo sorting at the MVB membrane
In simple terms: Proteins destined for vesicles are tagged and collected at the MVB membrane.
At the multivesicular body membrane, ubiquitinated transmembrane cargo is recognized by ESCRT-0, which recruits ESCRT-I and ESCRT-II to initiate sorting. This sequential assembly ensures that selected proteins are concentrated at sites of inward budding. The MVB membrane therefore acts as a sorting platform that determines which cargo enters intraluminal vesicles.
Membrane bending and intraluminal vesicle formation
In simple terms: The membrane curves inward to form small vesicles inside the MVB.
ESCRT-III and associated factors, including ALIX and syntenin, mediate membrane deformation and scission to generate intraluminal vesicles. Recent work shows that biomolecular condensates can also mediate bending and scission of endosome membranes, highlighting additional mechanisms at the MVB membrane. These events require coordinated lipid and protein remodeling.
MVB maturation and exosome release
In simple terms: The MVB can fuse with the cell surface to release its vesicles as exosomes.
After intraluminal vesicles form, the MVB can fuse with the plasma membrane, releasing intraluminal vesicles as exosomes. This step depends on the MVB membrane composition and on regulatory proteins that control fusion. Exosome release is a key output of MVB membrane function and is important in cancer and regenerative medicine.
Specialized MVB-like membrane trafficking
In simple terms: Some cells use MVB-like membranes for specialized transport tasks.
A multivesicular body-like organelle mediates stimulus-regulated trafficking of olfactory ciliary transduction proteins, demonstrating that MVB membrane principles apply to specialized cellular contexts. This finding broadens the relevance of GO:0032585 beyond canonical exosome biology.
Key Genes Involved in GO:0032585 multivesicular body membrane
The following genes and proteins are experimentally implicated in multivesicular body membrane function, ESCRT-dependent sorting, and exosome biogenesis.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TSG101 | ESCRT-I component; cargo sorting at MVB membrane | Knockout reduces exosome secretion; used to study MVB membrane sorting |
| VPS4A | AAA-ATPase mediating ESCRT disassembly and scission | Dominant-negative and KO models block intraluminal vesicle formation |
| VPS4B | AAA-ATPase paralog of VPS4A | Point mutations used to dissect ESCRT recycling at MVB membrane |
| ALIX | Accessory ESCRT protein; binds syntenin and CHMP4 | Knockout alters exosome cargo and MVB membrane dynamics |
| SDCBP (syntenin) | Adaptor linking cargo to ESCRT-III via ALIX | Overexpression increases exosome release; KO reduces it |
| CHMP4B | ESCRT-III subunit; membrane scission | Point mutations impair MVB membrane budding |
| HGS (HRS) | ESCRT-0 subunit; ubiquitin cargo recognition | Knockdown mis-sorts cargo at MVB membrane |
| STAM1 | ESCRT-0 subunit; ubiquitin binding | KO models show defective MVB sorting |
| VPS36 | ESCRT-II subunit; cargo and ESCRT-III recruitment | Knockdown affects intraluminal vesicle formation |
| SMPD3 (nSMase2) | Ceramide production at MVB membrane | Inhibition reduces exosome secretion; studied in cancer |
| RAB27A | Regulates MVB docking and fusion with plasma membrane | Knockout reduces exosome release |
| RAB27B | Rab GTPase involved in MVB trafficking | Overexpression enhances exosome secretion |
| GPR143 | Controls ESCRT-dependent exosome biogenesis | Knockout reduces exosome production and metastasis |
| PDCD6IP (ALIX) | Alias for ALIX; ESCRT accessory | Used in knock-in tagging to track MVB membrane |
| CHMP2A | ESCRT-III subunit | KO impairs MVB membrane scission |
| VPS25 | ESCRT-II subunit | Mutations affect MVB sorting |
| VPS28 | ESCRT-I subunit | Knockdown alters exosome cargo |
| VPS37B | ESCRT-I subunit | Studied in MVB membrane assembly |
How Is multivesicular body membrane Regulated?
The multivesicular body membrane and its associated sorting events are regulated by ESCRT assembly and disassembly cycles, which require ATP hydrolysis by VPS4. Accessory proteins such as ALIX and syntenin modulate ESCRT-III recruitment and exosome cargo selection. Rab GTPases, including RAB27A and RAB27B, control MVB docking and fusion with the plasma membrane, thereby regulating exosome release. Lipid composition, including ceramide generated by nSMase2, also influences MVB membrane budding. Additionally, biomolecular condensates can regulate membrane bending and scission, adding a layer of physical regulation.
multivesicular body membrane and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GPR143 | Cancer metastasis via ESCRT-dependent exosome biogenesis | Knockout in cancer cell lines; metastasis assays |
| TSG101 | Tumor progression and exosome secretion | Knockout and rescue in cancer cells |
| RAB27A | Exosome release in cancer and immune regulation | Knockout mice and cell lines |
| SMPD3 | Ceramide-dependent exosome biogenesis in cancer | Overexpression and point mutation |
| ALIX | Neurodegeneration and exosome cargo sorting | Knock-in tagging and knockout neurons |
Cancer and metastasis
MVB membrane dysfunction alters exosome cargo and secretion, promoting tumor progression and metastasis. GPR143 controls ESCRT-dependent exosome biogenesis and promotes cancer metastasis, linking MVB membrane machinery to aggressive disease. Exosomes derived from MVB membranes can reprogram recipient cells in the tumor microenvironment.
Neurodegeneration
Defective MVB membrane sorting and exosome release are implicated in neurodegenerative diseases, where altered protein clearance contributes to pathology. The MVB membrane is a key site for sorting proteins that aggregate in neurons.
Regenerative medicine
Mesenchymal stem cell-derived exosomes, which originate from MVB membranes, are explored for regenerative therapies. Understanding MVB membrane biology can improve exosome-based therapeutics.
From multivesicular body membrane-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a gene control MVB membrane budding? | CRISPR knockout in HeLa or HEK293 cells |
| Does a point mutation alter ESCRT assembly? | Point-mutation knock-in of VPS4 or CHMP4B |
| Where does a protein localize at the MVB membrane? | Tagged knock-in with fluorescent protein |
| Does overexpression increase exosome release? | Overexpression of SDCBP or RAB27B |
| Does a gene affect exosome cargo? | Knockout followed by proteomics and RNA-seq |
| Does a gene regulate MVB fusion? | Knockout of RAB27A with live imaging |
How to Study the multivesicular body membrane Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Electron microscopy | MVB membrane and intraluminal vesicle morphology | Ultrastructural analysis |
| Live-cell fluorescence imaging | ESCRT dynamics at MVB membrane | Real-time budding and scission |
| Mass spectrometry | Exosome protein cargo | Proteomic profiling after knockout |
| CRISPR library screening | Genes affecting exosome biogenesis | Discovery of MVB membrane regulators |
| Western blot | Protein levels of ESCRT components | Validation of knockout or overexpression |
| Nanoparticle tracking analysis | Exosome size and concentration | Quantifying exosome release |
| Immunoprecipitation | Protein interactions at MVB membrane | Mapping ESCRT complexes |
| RNA-seq | Transcriptional changes after perturbation | Pathway analysis in MVB membrane models |
Imaging MVB membrane dynamics
Fluorescence and electron microscopy visualize MVB membrane morphology and intraluminal vesicles. Live-cell imaging of tagged ESCRT proteins reveals real-time budding and scission events.
Proteomic analysis of exosomes
Mass spectrometry of exosomes isolated from MVB membrane pathways identifies cargo and validates sorting mechanisms. Comparative proteomics after knockout reveals specific MVB membrane dependencies.
Genetic screens for MVB membrane regulators
CRISPR library screening identifies genes required for exosome biogenesis and MVB membrane function. Hits can be validated by knockout and rescue experiments.
Biochemical assays of ESCRT function
In vitro reconstitution and ubiquitin-binding assays measure ESCRT recruitment to MVB membranes. ATPase assays assess VPS4 activity.
How CRISPR Can Be Used to Study GO:0032585 multivesicular body membrane
Knockout
CRISPR knockout of ESCRT genes such as TSG101 or VPS4A disrupts MVB membrane sorting and exosome secretion, providing causal evidence for their roles. Knockout cell lines are used to test rescue by wild-type or mutant constructs.
Point Mutation
Point-mutation knock-in of VPS4A or CHMP4B allows dissection of ATPase or membrane-scission domains at the MVB membrane. These models distinguish catalytic from scaffolding functions.
Knock-in
Tagged knock-in of ALIX or syntenin enables tracking of MVB membrane proteins in live cells. Knock-in of reporters can quantify exosome release dynamics.
Overexpression
Overexpression of SDCBP or RAB27B increases exosome release and alters MVB membrane cargo, modeling gain-of-function states in cancer. Overexpression models complement knockout studies.
How EDITGENE Supports multivesicular body membrane Research
Researchers studying multivesicular body membrane-related genes often need to determine whether a candidate gene is causally involved in MVB membrane function, exosome biogenesis, or disease progression. EDITGENE provides CRISPR-based cell models and screening services to test these hypotheses rigorously.
Contact EDITGENE today to design your custom CRISPR model for multivesicular body membrane research.
Frequently Asked Questions About multivesicular body membrane
What is GO:0032585 multivesicular body membrane?
GO:0032585 is the Gene Ontology term for the lipid bilayer surrounding a multivesicular body, the endosomal compartment containing intraluminal vesicles.
What genes are involved in multivesicular body membrane function?
Key genes include TSG101, VPS4A, VPS4B, ALIX, SDCBP, CHMP4B, HGS, STAM1, VPS36, SMPD3, RAB27A, RAB27B, and GPR143.
How is the multivesicular body membrane linked to exosomes?
Intraluminal vesicles formed at the MVB membrane can be released as exosomes when the MVB fuses with the plasma membrane.
What is the role of ESCRT at the multivesicular body membrane?
ESCRT complexes sort ubiquitinated cargo and mediate inward budding and scission of intraluminal vesicles at the MVB membrane.
Which diseases involve multivesicular body membrane dysfunction?
Cancer metastasis and neurodegenerative diseases are linked to altered MVB membrane sorting and exosome secretion.
How can I study multivesicular body membrane genes with CRISPR?
CRISPR knockout, point-mutation, knock-in, and overexpression models can test gene function in MVB membrane biology and exosome release.
What is the difference between MVB membrane and exosome membrane?
The MVB membrane is the limiting bilayer of the multivesicular body, while exosome membrane derives from intraluminal vesicles released upon MVB fusion.
What methods visualize the multivesicular body membrane?
Electron microscopy and live-cell fluorescence imaging of tagged ESCRT proteins visualize MVB membrane dynamics.
Is GPR143 involved in multivesicular body membrane biology?
GPR143 controls ESCRT-dependent exosome biogenesis and promotes cancer metastasis, implicating it in MVB membrane function.
Can CRISPR screening identify new MVB membrane regulators?
Yes, CRISPR library screening has been used to discover genes required for exosome biogenesis and MVB membrane function.
Conclusion
GO:0032585 (multivesicular body membrane) defines the lipid bilayer that surrounds the MVB and serves as the platform for ESCRT-dependent cargo sorting, intraluminal vesicle formation, and exosome release. Its molecular machinery, including ESCRT complexes, ALIX, syntenin, and Rab GTPases, is central to cancer biology, neurodegeneration, and regenerative medicine. CRISPR-based models and screening approaches provide powerful tools to dissect these mechanisms and identify therapeutic targets.
References
- 1. Hade MD et al.. 2021. Mesenchymal Stem Cell-Derived Exosomes: Applications in Regenerative Medicine.. Cells 10(8) PMID: 34440728
- 2. Arya SB et al.. 2024. The ins-and-outs of exosome biogenesis, secretion, and internalization.. Trends Cell Biol 34(2):90-108 PMID: 37507251
- 3. Hessvik NP et al.. 2018. Current knowledge on exosome biogenesis and release.. Cell Mol Life Sci 75(2):193-208 PMID: 28733901
- 4. Henne WM et al.. 2011. The ESCRT pathway.. Dev Cell 21(1):77-91 PMID: 21763610
- 5. Lee YJ et al.. 2023. GPR143 controls ESCRT-dependent exosome biogenesis and promotes cancer metastasis.. Dev Cell 58(4):320-334.e8 PMID: 36800996
- 6. Wang Y et al.. 2024. Biomolecular condensates mediate bending and scission of endosome membranes.. Nature 634(8036):1204-1210 PMID: 39385023
- 7. Han QF et al.. 2022. Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer.. Mol Cancer 21(1):207 PMID: 36320056
- 8. Maurya DK et al.. 2022. A multivesicular body-like organelle mediates stimulus-regulated trafficking of olfactory ciliary transduction proteins.. Nat Commun 13(1):6889 PMID: 36371422
